Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis

• M. L. Arffa,

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  ⨯
• M. A. Zapf,

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  ⨯
• A. N. Kothari,

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  ⨯
• V. Chang,

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  ⨯
• G. N. Gupta,

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  ⨯
• X. Ding,

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  ⨯
• M. M. Al-Gayyar,

  Affiliations Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt, Department of Pharmaceutical Chemistry, University of Tabuk, Tabuk, Saudi Arabia

  ⨯
• W. Syn,

  Affiliations Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, South Carolina, United States of America, Section of Gastroenterology, Ralph H Johnson Veteran Affairs Medical Center, Charleston, South Carolina, United States of America

  ⨯
• N. M. Elsherbiny,

  Affiliation Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

  ⨯
• P. C. Kuo ,

  * E-mail: pkuo@lumc.edu

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  http://orcid.org/0000-0003-0904-8636

  ⨯
• Z. Mi

  Affiliation Department of Surgery, Loyola University Medical Center, Maywood, IL, United States of America

  ⨯